| MSFT | Microsoft Corp | 5.77% |
| META | Meta Platforms Inc Class A | 5.23% |
| XOM | Exxon Mobil Corp | 3.00% |
| MRK | Merck & Co Inc | 2.94% |
| JNJ | Johnson & Johnson | 2.54% |
| BAC | Bank of America Corp | 2.33% |
| VZ | Verizon Communications Inc | 2.25% |
| PFE | Pfizer Inc | 2.11% |
| PG | Procter & Gamble Co | 2.03% |
| JPM | JPMorgan Chase & Co | 2.02% |
GMOV aims for total return by investing in undervalued securities within the US stock market. The fund employs a combination of proprietary quantitative analysis and historical comparisons to evaluate stocks based on key financial indicators, such as asset valuation, cash flow, and future earnings potential. This evaluation process supports informed decisions about position sizes and sector allocations, while also integrating ESG criteria to avoid industries like cluster munitions and thermal coal. GMOV maintains a focus on US companies, ensuring at least 80% of its assets are linked to this market, which allows for potential concentration in specific sectors. To enhance liquidity, the fund can invest in the GMO US Treasury Fund and other money market instruments, enabling adjustments to market conditions.
GMO US Value ETF · Issued by GMO
No recent news for GMOV. The ingest cron pulls every 15 minutes during market hours.
See every ETF that holds GMOV - directly and through fund-of-funds look-through - ranked by weight, with Pro reverse screening.
Upgrade to Pro